Introduction to FluoGuide

Join us for a virtual live event on February 28 at 10.45, for an in-depth introduction to FluoGuide, a pioneer in precision cancer surgery. FluoGuide’s CEO, Morten Albrechtsen will here elaborate on the company’s innovative technology and exciting pipeline.

FluoGuide lights up cancer for greater surgical precision, improving the outcome for cancer patients through fluorescence-guided surgery. Their lead compound, FG001, has already shown promising results in Phase II trials for use in aggressive brain, head & neck, and lung cancers.

At this virtual event, you will also have the opportunity to ask questions directly to FluoGuide’s CEO.

Disclaimer: HC Andersen Capital receives payment from FluoGuide for a DigitalIR/Corporate Visibility agreement./Claus Thestrup kl. 16.50, 20-02-2024.